Related references
Note: Only part of the references are listed.Anti-fracture efficacy of zoledronate in subgroups of osteopenic postmenopausal women: secondary analysis of a randomized controlled trial
I. R. Reid et al.
JOURNAL OF INTERNAL MEDICINE (2019)
The Effect of a Screening and Treatment Program for the Prevention of Fractures in Older Women: A Randomized Pragmatic Trial
Thomas Merlijn et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2019)
European guidance for the diagnosis and management of osteoporosis in postmenopausal women
J. A. Kanis et al.
OSTEOPOROSIS INTERNATIONAL (2019)
Effectiveness of a two-step population-based osteoporosis screening program using FRAX: the randomized Risk-stratified Osteoporosis Strategy Evaluation (ROSE) study
K. H. Rubin et al.
OSTEOPOROSIS INTERNATIONAL (2018)
Screening for Osteoporosis to Prevent Fractures US Preventive Services Task Force Recommendation Statement
Susan J. Curry et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
Screening in the community to reduce fractures in older women (SCOOP): a randomised controlled trial
Lee Shepstone et al.
LANCET (2018)
A closer look at SCOOP: screening for fracture prevention
Karin M. A. Swart et al.
LANCET (2018)
Fracture Prevention with Zoledronate in Older Women with Osteopenia
Ian R. Reid et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Excess mortality after hip fracture in elderly persons from Europe and the USA: the CHANCES project
M. Katsoulis et al.
JOURNAL OF INTERNAL MEDICINE (2017)
Economic Consequences and Potentially Preventable Costs Related to Osteoporosis in the Netherlands
Tom Dunnewind et al.
VALUE IN HEALTH (2017)
Effectiveness of Breast Cancer Screening: Systematic Review and Meta-analysis to Update the 2009 US Preventive Services Task Force Recommendation
Heidi D. Nelson et al.
ANNALS OF INTERNAL MEDICINE (2016)
Screening for Colorectal Cancer: A Systematic Review and Meta-Analysis
Donna Fitzpatrick-Lewis et al.
CLINICAL COLORECTAL CANCER (2016)
Osteoporosis in the European Union: medical management, epidemiology and economic burden
E. Hernlund et al.
ARCHIVES OF OSTEOPOROSIS (2013)
Randomized controlled trial of a primary care-based screening program to identify older women with prevalent osteoporotic vertebral fractures: Cohort for skeletal health in Bristol and Avon (COSHIBA)
Emma M. Clark et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2012)
2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary
Alexandra Papaioannou et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2010)
The primary care osteoporosis risk of fracture screening (POROS) study: Design and baseline characteristics
Diane L. Schneider et al.
CONTEMPORARY CLINICAL TRIALS (2010)
Population screening for osteoporosis risk: a randomised control trial of medication use and fracture risk
R. J. Barr et al.
OSTEOPOROSIS INTERNATIONAL (2010)
Risedronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women
G. Wells et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2008)
Alendronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women
G. A. Wells et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2008)
Screening elderly women for risk of future fractures - Participation rates and impact on incidence of falls and fractures
RJ Barr et al.
CALCIFIED TISSUE INTERNATIONAL (2005)
Evaluation of three population-based strategies for fracture prevention - Results of the osteoporosis population-based risk assessment (OPRA) trial
AZ LaCroix et al.
MEDICAL CARE (2005)
Identifying postmenopausal women at high risk of fracture in populations: A comparison of three strategies
DSM Buist et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2002)